BLOG POST

13 Pharma Companies Withdraw Malaria Monotherapies

By
May 12, 2006

The WHO announced yesterday that 13 producers of single-drug artemisinin medicines for malaria have agreed to voluntarily phase them out in order to slow the progressions of drug resistance.

Disclaimer

CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.

Topics

HIV
HIV

More Reading

Meeting team of doctor and medical staff at hospital
Blog Post
Did Economists Really Get Africa’s AIDS Epidemic “Analytically Wrong”?
Tom Drake
and
Peter Baker
August 22, 2023
Blog Post
How Economists got Africa’s AIDS Epidemic Wrong
Justin Sandefur
May 31, 2023
Event
The Future of PEPFAR: A Conversation with Ambassador Dr. John Nkengasong
June 08, 2023
10:00—11:00 AM ET / 3:00 PM BST
CASE STUDIES
CGD Contributions to Enhancing the “Value for Money” of HIV/AIDS Financing
Cordelia Kenney
November 10, 2022